查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1604673

基因组学市场中的人工智慧：按产品、功能、应用和最终用户划分 - 2025-2030 年全球预测

Artificial Intelligence in Genomics Market by Offering (Services, Software), Function (Clinical Workflows, Gene Editing, Genome Sequencing), Application, End-User - Global Forecast 2025-2030
出版日期: | 出版商: 360iResearch | 英文 180 Pages | 商品交期: 最快1-2个工作天内

价格

※ 本网页内容可能与最新版本有所差异。详细情况请与我们联繫。

2023年，基因组学领域的人工智慧市场价值为5.6007亿美元，预计到2024年将达到7.4023亿美元，复合年增长率为32.65%，预计到2030年将达到40.483亿美元。

基因组学领域的人工智慧 (AI) 产业利用 AI 技术分析遗传资料并增强基因组研究，为个人化医疗、药物发现和疾病预测提供宝贵的见解。基因组学中人工智慧的范围扩展到资料驱动的医疗保健解决方案、改进的基因组诊断和突破性的基因研究，这对医学进步至关重要。产生的大量基因组资料需要复杂的计算模型来解释，这加剧了这种需求。人工智慧简化了复杂的资料处理，并提供更快的分析和更准确的结果。其用途广泛，包括管理基因组序列资料、利用人工智慧诊断遗传疾病以及製定个人化治疗计划。最终用途多种多样，包括医疗保健提供者、製药公司、研究实验室和学术机构。市场成长受到精准医疗需求不断增长、人工智慧技术进步以及对基因组研究日益增长的兴趣的影响。最新的商机在于人工智慧与次世代定序技术的融合，以及人工智慧主导的基因编辑工具的潜力。为公司提供的策略建议包括投资人工智慧平台开发以及与生物医学研究人员和技术专家的合作伙伴关係以推动创新。然而，这个市场面临着重大挑战，包括资料隐私问题、监管障碍、高昂的实施成本以及对人工智慧模型及其结果进行可靠检验的需要。克服这些限制需要专注于开发透明的人工智慧系统并遵守道德标准。创新和研究的完美领域包括探索人工智慧在揭示复杂的遗传交互作用中的作用以及开发预测基因组学工具。随着情势的迅速发展，相关人员必须保持敏捷，以应对法规环境并最大限度地发挥人工智慧在基因组学领域的潜力。由于其动态性，这个市场对于为新技术进步做出贡献的公司来说具有巨大的潜力。

主要市场统计
基准年[2023] 56007万美元
预测年份 [2024] 74023万美元
预测年份 [2030] 40.483 亿美元
复合年增长率（%） 32.65%

市场动态：基因组学市场快速发展的人工智慧的关键市场洞察

供需的动态交互作用正在改变基因组学领域的人工智慧市场。透过了解这些不断变化的市场动态，公司可以准备好做出明智的投资决策、完善策略决策并抓住新的商机。全面了解这些趋势可以帮助企业降低政治、地理、技术、社会和经济领域的风险，同时也能帮助企业了解消费行为及其对製造业的影响。

  • 市场驱动因素
    • 药物发现和药物开发产生的潜在需求
    • 製药和生物技术产业越来越多地采用自动化系统
    • 透过基因组解决方案持续投资新药发现
  • 市场限制因素
    • 人工智慧开发和实施的高成本
  • 市场机会
    • 提高人工智慧在临床试验资料管理中的适应性和高品质资料生成
    • 政府加大力度将人工智慧引入基因组学领域
  • 市场挑战
    • 缺乏与基因组学人工智慧相关的熟练专家和资料安全挑战

波特的五力：驾驭基因体学人工智慧市场的策略工具

波特的五力框架是了解市场竞争格局的重要工具。波特的五力框架为评估公司的竞争地位和探索策略机会提供了清晰的方法。该框架可帮助公司评估市场动态并确定新业务的盈利。这些见解使公司能够利用自己的优势，解决弱点并避免潜在的挑战，从而确保更强大的市场地位。

PESTLE分析：了解外部对基因组市场人工智慧的影响

外部宏观环境因素在塑造基因组学市场人工智慧的绩效动态方面发挥着至关重要的作用。对政治、经济、社会、技术、法律和环境因素的分析提供了应对这些影响所需的资讯。透过调查 PESTLE 因素，公司可以更了解潜在的风险和机会。这种分析可以帮助公司预测法规、消费者偏好和经济趋势的变化，并帮助他们做出积极主动的决策。

市场占有率分析 了解基因组学人工智慧市场的竞争格局

对基因组学市场中人工智慧的详细市场占有率分析可以对供应商绩效进行全面评估。公司可以透过比较收益、客户群和成长率等关键指标来揭示其竞争地位。该分析揭示了市场集中、分散和整合的趋势，为供应商提供了製定策略决策所需的洞察力，使他们能够在日益激烈的竞争中占有一席之地。

FPNV定位矩阵基因组学人工智慧市场厂商绩效评估

FPNV 定位矩阵是评估基因组学市场人工智慧供应商的关键工具。此矩阵允许业务组织根据商务策略和产品满意度评估供应商，从而做出与其目标相符的明智决策。这四个象限使您能够清晰、准确地划分供应商，并确定最能满足您的策略目标的合作伙伴和解决方案。

在策略分析和推荐基因组学方面绘製人工智慧市场的成功之路

对于旨在加强其在全球市场的影响力的公司来说，基因组市场人工智慧的策略分析至关重要。透过审查关键资源、能力和绩效指标，公司可以识别成长机会并努力改进。这种方法使您能够克服竞争环境中的挑战，利用新的商机并取得长期成功。

本报告对市场进行了全面分析，涵盖关键重点领域：

1. 市场渗透率：详细检视当前市场环境、主要企业的广泛资料、评估其在市场中的影响力和整体影响力。

2. 市场开拓：辨识新兴市场的成长机会，评估现有领域的扩张潜力，并提供未来成长的策略蓝图。

3. 市场多元化：分析近期产品发布、开拓地区、关键产业进展、塑造市场的策略投资。

4. 竞争评估与情报：彻底分析竞争格局，检验市场占有率、业务策略、产品系列、认证、监理核准、专利趋势、主要企业的技术进步等。

5. 产品开发与创新：重点关注可望推动未来市场成长的最尖端科技、研发活动和产品创新。

我们也回答重要问题，帮助相关人员做出明智的决策：

1.目前的市场规模和未来的成长预测是多少？

2. 哪些产品、区隔市场和地区提供最佳投资机会？

3.塑造市场的主要技术趋势和监管影响是什么？

4.主要厂商的市场占有率和竞争地位如何？

5. 推动供应商市场进入和退出策略的收益来源和策略机会是什么？

目录

第一章 前言

第二章调查方法

第三章执行摘要

第四章市场概况

第五章市场洞察

  • 市场动态
    • 促进因素
      • 药物发现和开发的潜在需求
      • 製药和生物技术产业越来越多地采用自动化系统
      • 透过基因组解决方案持续投资新药发现
    • 抑制因素
      • 开发和部署人工智慧的高成本
    • 机会
      • 提高人工智慧在临床试验资料管理和高品质资料生成方面的适应性
      • 政府在基因组学领域引入人工智慧的努力活性化
    • 任务
      • 缺乏与基因组学人工智慧相关的熟练专业人员和资料安全挑战
  • 市场区隔分析
  • 波特五力分析
  • PESTEL分析
    • 政治的
    • 经济
    • 社群
    • 技术的
    • 合法地
    • 环境

第六章 基因组学中的人工智慧市场：透过提供

  • 服务
  • 软体

第七章 基因组学中的人工智慧市场：按功能

  • 临床工作流程
  • 基因编辑
  • 基因组序列分析
  • 预测基因检测与预防医学

第八章基因组学中的人工智慧市场：按应用分类

  • 农业和动物研究
  • 诊断
  • 药物发现与开发
  • 精准医疗

第九章 基因组学中的人工智慧市场：按最终用户划分

  • 政府机构
  • 医疗服务提供方
  • 製药和生物技术公司
  • 研究中心和学术机构

第十章 美洲基因体学人工智慧市场

  • 阿根廷
  • 巴西
  • 加拿大
  • 墨西哥
  • 美国

第十一章 亚太地区基因体学人工智慧市场

  • 澳洲
  • 中国
  • 印度
  • 印尼
  • 日本
  • 马来西亚
  • 菲律宾
  • 新加坡
  • 韩国
  • 台湾
  • 泰国
  • 越南

第十二章：欧洲、中东和非洲基因组学人工智慧市场

  • 丹麦
  • 埃及
  • 芬兰
  • 法国
  • 德国
  • 以色列
  • 义大利
  • 荷兰
  • 奈及利亚
  • 挪威
  • 波兰
  • 卡达
  • 俄罗斯
  • 沙乌地阿拉伯
  • 南非
  • 西班牙
  • 瑞典
  • 瑞士
  • 土耳其
  • 阿拉伯聯合大公国
  • 英国

第十三章竞争格局

  • 2023 年市场占有率分析
  • FPNV 定位矩阵，2023
  • 竞争情境分析
  • 战略分析和建议

公司名单

  • BenevolentAI Ltd.
  • Data4Cure Inc.
  • Deep Genomics Inc.
  • DNAnexus Inc.
  • Engine Biosciences Pte. Ltd.
  • Exscientia
  • Fabric Genomics Inc.
  • FDNA Inc.
  • Freenome Holdings, Inc.
  • Genomics AI
  • Genoox Ltd.
  • Illumina, Inc.
  • insitro
  • International Business Machines Corporation
  • Invitae Corporation
  • LGC Biosearch Technologies
  • Lifebit Biotech Ltd
  • Microsoft Corporation
  • MolecularMatch, Inc.
  • NVIDIA Corporation
  • Ocean Genomics
  • Owkin, Inc
  • PrecisionLife Ltd.
  • Sophia Genetics SA
  • Verge Genomics
Product Code: MRR-501246436E27

The Artificial Intelligence in Genomics Market was valued at USD 560.07 million in 2023, expected to reach USD 740.23 million in 2024, and is projected to grow at a CAGR of 32.65%, to USD 4,048.30 million by 2030.

The artificial intelligence (AI) in genomics industry involves leveraging AI technologies to analyze genetic data and enhance genomic research, offering invaluable insights into personalized medicine, drug discovery, and disease prediction. The scope of AI in genomics extends across data-driven healthcare solutions, improved genomic diagnostics, and groundbreaking genetic research, crucial for advancing medical science. Its necessity is underscored by the vast amount of genomic data generated that requires sophisticated computational models for interpretation. AI simplifies complex data processing, providing accelerated analysis and more precise outcomes. The applications span the management of genomic sequencing data, AI-powered diagnostics for genetic disorders, and the development of personalized treatment plans. End-use scope is vast, targeting healthcare providers, pharmaceutical companies, research laboratories, and academic institutions. Market growth is being influenced by increasing demand for precision medicine, advancements in AI technologies, and a rising interest in genomic research. The latest opportunities lie in the integration of AI with next-generation sequencing technologies and the potential for AI-driven gene editing tools. For businesses, strategic recommendations include investing in AI platform development and collaborative partnerships with biomedical researchers and technology experts to drive innovation. However, the market faces significant challenges, including data privacy concerns, regulatory hurdles, high costs of implementation, and a need for robust validation of AI models and their outcomes. Overcoming these limitations requires a focus on developing transparent AI systems and adhering to ethical standards. The best areas for innovation and research include exploring AI's role in dissecting complex genetic interactions and developing tools for predictive genomics. As the landscape rapidly evolves, stakeholders must remain agile to navigate regulatory environments and harness AI's full potential in genomics. With its dynamic nature, the market presents substantial possibilities for businesses poised to contribute to its emerging technological advancements.

KEY MARKET STATISTICS
Base Year [2023] USD 560.07 million
Estimated Year [2024] USD 740.23 million
Forecast Year [2030] USD 4,048.30 million
CAGR (%) 32.65%

Market Dynamics: Unveiling Key Market Insights in the Rapidly Evolving Artificial Intelligence in Genomics Market

The Artificial Intelligence in Genomics Market is undergoing transformative changes driven by a dynamic interplay of supply and demand factors. Understanding these evolving market dynamics prepares business organizations to make informed investment decisions, refine strategic decisions, and seize new opportunities. By gaining a comprehensive view of these trends, business organizations can mitigate various risks across political, geographic, technical, social, and economic domains while also gaining a clearer understanding of consumer behavior and its impact on manufacturing costs and purchasing trends.

  • Market Drivers
    • Potential demand attributed to drug discovery and drug developments
    • Increasing adoption of automated systems in pharmaceuticals and biotechnology industries
    • Ongoing investments in novel drug discoveries with genomic solutions
  • Market Restraints
    • High costs associated with development and deployment of AI
  • Market Opportunities
    • Growing adaptability of AI for clinical trials data management along with high-quality data generation
    • Upsurging governmental initiatives for AI deployment in genomics
  • Market Challenges
    • Scarcity of skilled professionals and data security challenges associated with AI in genomics

Porter's Five Forces: A Strategic Tool for Navigating the Artificial Intelligence in Genomics Market

Porter's five forces framework is a critical tool for understanding the competitive landscape of the Artificial Intelligence in Genomics Market. It offers business organizations with a clear methodology for evaluating their competitive positioning and exploring strategic opportunities. This framework helps businesses assess the power dynamics within the market and determine the profitability of new ventures. With these insights, business organizations can leverage their strengths, address weaknesses, and avoid potential challenges, ensuring a more resilient market positioning.

PESTLE Analysis: Navigating External Influences in the Artificial Intelligence in Genomics Market

External macro-environmental factors play a pivotal role in shaping the performance dynamics of the Artificial Intelligence in Genomics Market. Political, Economic, Social, Technological, Legal, and Environmental factors analysis provides the necessary information to navigate these influences. By examining PESTLE factors, businesses can better understand potential risks and opportunities. This analysis enables business organizations to anticipate changes in regulations, consumer preferences, and economic trends, ensuring they are prepared to make proactive, forward-thinking decisions.

Market Share Analysis: Understanding the Competitive Landscape in the Artificial Intelligence in Genomics Market

A detailed market share analysis in the Artificial Intelligence in Genomics Market provides a comprehensive assessment of vendors' performance. Companies can identify their competitive positioning by comparing key metrics, including revenue, customer base, and growth rates. This analysis highlights market concentration, fragmentation, and trends in consolidation, offering vendors the insights required to make strategic decisions that enhance their position in an increasingly competitive landscape.

FPNV Positioning Matrix: Evaluating Vendors' Performance in the Artificial Intelligence in Genomics Market

The Forefront, Pathfinder, Niche, Vital (FPNV) Positioning Matrix is a critical tool for evaluating vendors within the Artificial Intelligence in Genomics Market. This matrix enables business organizations to make well-informed decisions that align with their goals by assessing vendors based on their business strategy and product satisfaction. The four quadrants provide a clear and precise segmentation of vendors, helping users identify the right partners and solutions that best fit their strategic objectives.

Strategy Analysis & Recommendation: Charting a Path to Success in the Artificial Intelligence in Genomics Market

A strategic analysis of the Artificial Intelligence in Genomics Market is essential for businesses looking to strengthen their global market presence. By reviewing key resources, capabilities, and performance indicators, business organizations can identify growth opportunities and work toward improvement. This approach helps businesses navigate challenges in the competitive landscape and ensures they are well-positioned to capitalize on newer opportunities and drive long-term success.

Key Company Profiles

The report delves into recent significant developments in the Artificial Intelligence in Genomics Market, highlighting leading vendors and their innovative profiles. These include BenevolentAI Ltd., Data4Cure Inc., Deep Genomics Inc., DNAnexus Inc., Engine Biosciences Pte. Ltd., Exscientia, Fabric Genomics Inc., FDNA Inc., Freenome Holdings, Inc., Genomics AI, Genoox Ltd., Illumina, Inc., insitro, International Business Machines Corporation, Invitae Corporation, LGC Biosearch Technologies, Lifebit Biotech Ltd, Microsoft Corporation, MolecularMatch, Inc., NVIDIA Corporation, Ocean Genomics, Owkin, Inc, PrecisionLife Ltd., Sophia Genetics SA, and Verge Genomics.

Market Segmentation & Coverage

This research report categorizes the Artificial Intelligence in Genomics Market to forecast the revenues and analyze trends in each of the following sub-markets:

  • Based on Offering, market is studied across Services and Software.
  • Based on Function, market is studied across Clinical Workflows, Gene Editing, Genome Sequencing, and Predictive Genetic Testing & Preventive Medicine.
  • Based on Application, market is studied across Agriculture & Animal Research, Diagnostics, Drug Discovery & Development, and Precision Medicine.
  • Based on End-User, market is studied across Government Organizations, Healthcare Providers, Pharmaceutical & Biotech Companies, and Research Centers & Academic Institutes.
  • Based on Region, market is studied across Americas, Asia-Pacific, and Europe, Middle East & Africa. The Americas is further studied across Argentina, Brazil, Canada, Mexico, and United States. The United States is further studied across California, Florida, Illinois, New York, Ohio, Pennsylvania, and Texas. The Asia-Pacific is further studied across Australia, China, India, Indonesia, Japan, Malaysia, Philippines, Singapore, South Korea, Taiwan, Thailand, and Vietnam. The Europe, Middle East & Africa is further studied across Denmark, Egypt, Finland, France, Germany, Israel, Italy, Netherlands, Nigeria, Norway, Poland, Qatar, Russia, Saudi Arabia, South Africa, Spain, Sweden, Switzerland, Turkey, United Arab Emirates, and United Kingdom.

The report offers a comprehensive analysis of the market, covering key focus areas:

1. Market Penetration: A detailed review of the current market environment, including extensive data from top industry players, evaluating their market reach and overall influence.

2. Market Development: Identifies growth opportunities in emerging markets and assesses expansion potential in established sectors, providing a strategic roadmap for future growth.

3. Market Diversification: Analyzes recent product launches, untapped geographic regions, major industry advancements, and strategic investments reshaping the market.

4. Competitive Assessment & Intelligence: Provides a thorough analysis of the competitive landscape, examining market share, business strategies, product portfolios, certifications, regulatory approvals, patent trends, and technological advancements of key players.

5. Product Development & Innovation: Highlights cutting-edge technologies, R&D activities, and product innovations expected to drive future market growth.

The report also answers critical questions to aid stakeholders in making informed decisions:

1. What is the current market size, and what is the forecasted growth?

2. Which products, segments, and regions offer the best investment opportunities?

3. What are the key technology trends and regulatory influences shaping the market?

4. How do leading vendors rank in terms of market share and competitive positioning?

5. What revenue sources and strategic opportunities drive vendors' market entry or exit strategies?

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Segmentation & Coverage
  • 1.3. Years Considered for the Study
  • 1.4. Currency & Pricing
  • 1.5. Language
  • 1.6. Stakeholders

2. Research Methodology

  • 2.1. Define: Research Objective
  • 2.2. Determine: Research Design
  • 2.3. Prepare: Research Instrument
  • 2.4. Collect: Data Source
  • 2.5. Analyze: Data Interpretation
  • 2.6. Formulate: Data Verification
  • 2.7. Publish: Research Report
  • 2.8. Repeat: Report Update

3. Executive Summary

4. Market Overview

5. Market Insights

  • 5.1. Market Dynamics
    • 5.1.1. Drivers
      • 5.1.1.1. Potential demand attributed to drug discovery and drug developments
      • 5.1.1.2. Increasing adoption of automated systems in pharmaceuticals and biotechnology industries
      • 5.1.1.3. Ongoing investments in novel drug discoveries with genomic solutions
    • 5.1.2. Restraints
      • 5.1.2.1. High costs associated with development and deployment of AI
    • 5.1.3. Opportunities
      • 5.1.3.1. Growing adaptability of AI for clinical trials data management along with high-quality data generation
      • 5.1.3.2. Upsurging governmental initiatives for AI deployment in genomics
    • 5.1.4. Challenges
      • 5.1.4.1. Scarcity of skilled professionals and data security challenges associated with AI in genomics
  • 5.2. Market Segmentation Analysis
  • 5.3. Porter's Five Forces Analysis
    • 5.3.1. Threat of New Entrants
    • 5.3.2. Threat of Substitutes
    • 5.3.3. Bargaining Power of Customers
    • 5.3.4. Bargaining Power of Suppliers
    • 5.3.5. Industry Rivalry
  • 5.4. PESTLE Analysis
    • 5.4.1. Political
    • 5.4.2. Economic
    • 5.4.3. Social
    • 5.4.4. Technological
    • 5.4.5. Legal
    • 5.4.6. Environmental

6. Artificial Intelligence in Genomics Market, by Offering

  • 6.1. Introduction
  • 6.2. Services
  • 6.3. Software

7. Artificial Intelligence in Genomics Market, by Function

  • 7.1. Introduction
  • 7.2. Clinical Workflows
  • 7.3. Gene Editing
  • 7.4. Genome Sequencing
  • 7.5. Predictive Genetic Testing & Preventive Medicine

8. Artificial Intelligence in Genomics Market, by Application

  • 8.1. Introduction
  • 8.2. Agriculture & Animal Research
  • 8.3. Diagnostics
  • 8.4. Drug Discovery & Development
  • 8.5. Precision Medicine

9. Artificial Intelligence in Genomics Market, by End-User

  • 9.1. Introduction
  • 9.2. Government Organizations
  • 9.3. Healthcare Providers
  • 9.4. Pharmaceutical & Biotech Companies
  • 9.5. Research Centers & Academic Institutes

10. Americas Artificial Intelligence in Genomics Market

  • 10.1. Introduction
  • 10.2. Argentina
  • 10.3. Brazil
  • 10.4. Canada
  • 10.5. Mexico
  • 10.6. United States

11. Asia-Pacific Artificial Intelligence in Genomics Market

  • 11.1. Introduction
  • 11.2. Australia
  • 11.3. China
  • 11.4. India
  • 11.5. Indonesia
  • 11.6. Japan
  • 11.7. Malaysia
  • 11.8. Philippines
  • 11.9. Singapore
  • 11.10. South Korea
  • 11.11. Taiwan
  • 11.12. Thailand
  • 11.13. Vietnam

12. Europe, Middle East & Africa Artificial Intelligence in Genomics Market

  • 12.1. Introduction
  • 12.2. Denmark
  • 12.3. Egypt
  • 12.4. Finland
  • 12.5. France
  • 12.6. Germany
  • 12.7. Israel
  • 12.8. Italy
  • 12.9. Netherlands
  • 12.10. Nigeria
  • 12.11. Norway
  • 12.12. Poland
  • 12.13. Qatar
  • 12.14. Russia
  • 12.15. Saudi Arabia
  • 12.16. South Africa
  • 12.17. Spain
  • 12.18. Sweden
  • 12.19. Switzerland
  • 12.20. Turkey
  • 12.21. United Arab Emirates
  • 12.22. United Kingdom

13. Competitive Landscape

  • 13.1. Market Share Analysis, 2023
  • 13.2. FPNV Positioning Matrix, 2023
  • 13.3. Competitive Scenario Analysis
  • 13.4. Strategy Analysis & Recommendation

Companies Mentioned

  • 1. BenevolentAI Ltd.
  • 2. Data4Cure Inc.
  • 3. Deep Genomics Inc.
  • 4. DNAnexus Inc.
  • 5. Engine Biosciences Pte. Ltd.
  • 6. Exscientia
  • 7. Fabric Genomics Inc.
  • 8. FDNA Inc.
  • 9. Freenome Holdings, Inc.
  • 10. Genomics AI
  • 11. Genoox Ltd.
  • 12. Illumina, Inc.
  • 13. insitro
  • 14. International Business Machines Corporation
  • 15. Invitae Corporation
  • 16. LGC Biosearch Technologies
  • 17. Lifebit Biotech Ltd
  • 18. Microsoft Corporation
  • 19. MolecularMatch, Inc.
  • 20. NVIDIA Corporation
  • 21. Ocean Genomics
  • 22. Owkin, Inc
  • 23. PrecisionLife Ltd.
  • 24. Sophia Genetics SA
  • 25. Verge Genomics

LIST OF FIGURES

  • FIGURE 1. ARTIFICIAL INTELLIGENCE IN GENOMICS MARKET RESEARCH PROCESS
  • FIGURE 2. ARTIFICIAL INTELLIGENCE IN GENOMICS MARKET SIZE, 2023 VS 2030
  • FIGURE 3. GLOBAL ARTIFICIAL INTELLIGENCE IN GENOMICS MARKET SIZE, 2018-2030 (USD MILLION)
  • FIGURE 4. GLOBAL ARTIFICIAL INTELLIGENCE IN GENOMICS MARKET SIZE, BY REGION, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 5. GLOBAL ARTIFICIAL INTELLIGENCE IN GENOMICS MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 6. GLOBAL ARTIFICIAL INTELLIGENCE IN GENOMICS MARKET SIZE, BY OFFERING, 2023 VS 2030 (%)
  • FIGURE 7. GLOBAL ARTIFICIAL INTELLIGENCE IN GENOMICS MARKET SIZE, BY OFFERING, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 8. GLOBAL ARTIFICIAL INTELLIGENCE IN GENOMICS MARKET SIZE, BY FUNCTION, 2023 VS 2030 (%)
  • FIGURE 9. GLOBAL ARTIFICIAL INTELLIGENCE IN GENOMICS MARKET SIZE, BY FUNCTION, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 10. GLOBAL ARTIFICIAL INTELLIGENCE IN GENOMICS MARKET SIZE, BY APPLICATION, 2023 VS 2030 (%)
  • FIGURE 11. GLOBAL ARTIFICIAL INTELLIGENCE IN GENOMICS MARKET SIZE, BY APPLICATION, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 12. GLOBAL ARTIFICIAL INTELLIGENCE IN GENOMICS MARKET SIZE, BY END-USER, 2023 VS 2030 (%)
  • FIGURE 13. GLOBAL ARTIFICIAL INTELLIGENCE IN GENOMICS MARKET SIZE, BY END-USER, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 14. AMERICAS ARTIFICIAL INTELLIGENCE IN GENOMICS MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 15. AMERICAS ARTIFICIAL INTELLIGENCE IN GENOMICS MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 16. UNITED STATES ARTIFICIAL INTELLIGENCE IN GENOMICS MARKET SIZE, BY STATE, 2023 VS 2030 (%)
  • FIGURE 17. UNITED STATES ARTIFICIAL INTELLIGENCE IN GENOMICS MARKET SIZE, BY STATE, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 18. ASIA-PACIFIC ARTIFICIAL INTELLIGENCE IN GENOMICS MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 19. ASIA-PACIFIC ARTIFICIAL INTELLIGENCE IN GENOMICS MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 20. EUROPE, MIDDLE EAST & AFRICA ARTIFICIAL INTELLIGENCE IN GENOMICS MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 21. EUROPE, MIDDLE EAST & AFRICA ARTIFICIAL INTELLIGENCE IN GENOMICS MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 22. ARTIFICIAL INTELLIGENCE IN GENOMICS MARKET SHARE, BY KEY PLAYER, 2023
  • FIGURE 23. ARTIFICIAL INTELLIGENCE IN GENOMICS MARKET, FPNV POSITIONING MATRIX, 2023

LIST OF TABLES

  • TABLE 1. ARTIFICIAL INTELLIGENCE IN GENOMICS MARKET SEGMENTATION & COVERAGE
  • TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2023
  • TABLE 3. GLOBAL ARTIFICIAL INTELLIGENCE IN GENOMICS MARKET SIZE, 2018-2030 (USD MILLION)
  • TABLE 4. GLOBAL ARTIFICIAL INTELLIGENCE IN GENOMICS MARKET SIZE, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 5. GLOBAL ARTIFICIAL INTELLIGENCE IN GENOMICS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 6. ARTIFICIAL INTELLIGENCE IN GENOMICS MARKET DYNAMICS
  • TABLE 7. GLOBAL ARTIFICIAL INTELLIGENCE IN GENOMICS MARKET SIZE, BY OFFERING, 2018-2030 (USD MILLION)
  • TABLE 8. GLOBAL ARTIFICIAL INTELLIGENCE IN GENOMICS MARKET SIZE, BY SERVICES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 9. GLOBAL ARTIFICIAL INTELLIGENCE IN GENOMICS MARKET SIZE, BY SOFTWARE, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 10. GLOBAL ARTIFICIAL INTELLIGENCE IN GENOMICS MARKET SIZE, BY FUNCTION, 2018-2030 (USD MILLION)
  • TABLE 11. GLOBAL ARTIFICIAL INTELLIGENCE IN GENOMICS MARKET SIZE, BY CLINICAL WORKFLOWS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 12. GLOBAL ARTIFICIAL INTELLIGENCE IN GENOMICS MARKET SIZE, BY GENE EDITING, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 13. GLOBAL ARTIFICIAL INTELLIGENCE IN GENOMICS MARKET SIZE, BY GENOME SEQUENCING, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 14. GLOBAL ARTIFICIAL INTELLIGENCE IN GENOMICS MARKET SIZE, BY PREDICTIVE GENETIC TESTING & PREVENTIVE MEDICINE, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 15. GLOBAL ARTIFICIAL INTELLIGENCE IN GENOMICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 16. GLOBAL ARTIFICIAL INTELLIGENCE IN GENOMICS MARKET SIZE, BY AGRICULTURE & ANIMAL RESEARCH, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 17. GLOBAL ARTIFICIAL INTELLIGENCE IN GENOMICS MARKET SIZE, BY DIAGNOSTICS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 18. GLOBAL ARTIFICIAL INTELLIGENCE IN GENOMICS MARKET SIZE, BY DRUG DISCOVERY & DEVELOPMENT, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 19. GLOBAL ARTIFICIAL INTELLIGENCE IN GENOMICS MARKET SIZE, BY PRECISION MEDICINE, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 20. GLOBAL ARTIFICIAL INTELLIGENCE IN GENOMICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 21. GLOBAL ARTIFICIAL INTELLIGENCE IN GENOMICS MARKET SIZE, BY GOVERNMENT ORGANIZATIONS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 22. GLOBAL ARTIFICIAL INTELLIGENCE IN GENOMICS MARKET SIZE, BY HEALTHCARE PROVIDERS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 23. GLOBAL ARTIFICIAL INTELLIGENCE IN GENOMICS MARKET SIZE, BY PHARMACEUTICAL & BIOTECH COMPANIES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 24. GLOBAL ARTIFICIAL INTELLIGENCE IN GENOMICS MARKET SIZE, BY RESEARCH CENTERS & ACADEMIC INSTITUTES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 25. AMERICAS ARTIFICIAL INTELLIGENCE IN GENOMICS MARKET SIZE, BY OFFERING, 2018-2030 (USD MILLION)
  • TABLE 26. AMERICAS ARTIFICIAL INTELLIGENCE IN GENOMICS MARKET SIZE, BY FUNCTION, 2018-2030 (USD MILLION)
  • TABLE 27. AMERICAS ARTIFICIAL INTELLIGENCE IN GENOMICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 28. AMERICAS ARTIFICIAL INTELLIGENCE IN GENOMICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 29. AMERICAS ARTIFICIAL INTELLIGENCE IN GENOMICS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 30. ARGENTINA ARTIFICIAL INTELLIGENCE IN GENOMICS MARKET SIZE, BY OFFERING, 2018-2030 (USD MILLION)
  • TABLE 31. ARGENTINA ARTIFICIAL INTELLIGENCE IN GENOMICS MARKET SIZE, BY FUNCTION, 2018-2030 (USD MILLION)
  • TABLE 32. ARGENTINA ARTIFICIAL INTELLIGENCE IN GENOMICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 33. ARGENTINA ARTIFICIAL INTELLIGENCE IN GENOMICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 34. BRAZIL ARTIFICIAL INTELLIGENCE IN GENOMICS MARKET SIZE, BY OFFERING, 2018-2030 (USD MILLION)
  • TABLE 35. BRAZIL ARTIFICIAL INTELLIGENCE IN GENOMICS MARKET SIZE, BY FUNCTION, 2018-2030 (USD MILLION)
  • TABLE 36. BRAZIL ARTIFICIAL INTELLIGENCE IN GENOMICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 37. BRAZIL ARTIFICIAL INTELLIGENCE IN GENOMICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 38. CANADA ARTIFICIAL INTELLIGENCE IN GENOMICS MARKET SIZE, BY OFFERING, 2018-2030 (USD MILLION)
  • TABLE 39. CANADA ARTIFICIAL INTELLIGENCE IN GENOMICS MARKET SIZE, BY FUNCTION, 2018-2030 (USD MILLION)
  • TABLE 40. CANADA ARTIFICIAL INTELLIGENCE IN GENOMICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 41. CANADA ARTIFICIAL INTELLIGENCE IN GENOMICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 42. MEXICO ARTIFICIAL INTELLIGENCE IN GENOMICS MARKET SIZE, BY OFFERING, 2018-2030 (USD MILLION)
  • TABLE 43. MEXICO ARTIFICIAL INTELLIGENCE IN GENOMICS MARKET SIZE, BY FUNCTION, 2018-2030 (USD MILLION)
  • TABLE 44. MEXICO ARTIFICIAL INTELLIGENCE IN GENOMICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 45. MEXICO ARTIFICIAL INTELLIGENCE IN GENOMICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 46. UNITED STATES ARTIFICIAL INTELLIGENCE IN GENOMICS MARKET SIZE, BY OFFERING, 2018-2030 (USD MILLION)
  • TABLE 47. UNITED STATES ARTIFICIAL INTELLIGENCE IN GENOMICS MARKET SIZE, BY FUNCTION, 2018-2030 (USD MILLION)
  • TABLE 48. UNITED STATES ARTIFICIAL INTELLIGENCE IN GENOMICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 49. UNITED STATES ARTIFICIAL INTELLIGENCE IN GENOMICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 50. UNITED STATES ARTIFICIAL INTELLIGENCE IN GENOMICS MARKET SIZE, BY STATE, 2018-2030 (USD MILLION)
  • TABLE 51. ASIA-PACIFIC ARTIFICIAL INTELLIGENCE IN GENOMICS MARKET SIZE, BY OFFERING, 2018-2030 (USD MILLION)
  • TABLE 52. ASIA-PACIFIC ARTIFICIAL INTELLIGENCE IN GENOMICS MARKET SIZE, BY FUNCTION, 2018-2030 (USD MILLION)
  • TABLE 53. ASIA-PACIFIC ARTIFICIAL INTELLIGENCE IN GENOMICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 54. ASIA-PACIFIC ARTIFICIAL INTELLIGENCE IN GENOMICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 55. ASIA-PACIFIC ARTIFICIAL INTELLIGENCE IN GENOMICS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 56. AUSTRALIA ARTIFICIAL INTELLIGENCE IN GENOMICS MARKET SIZE, BY OFFERING, 2018-2030 (USD MILLION)
  • TABLE 57. AUSTRALIA ARTIFICIAL INTELLIGENCE IN GENOMICS MARKET SIZE, BY FUNCTION, 2018-2030 (USD MILLION)
  • TABLE 58. AUSTRALIA ARTIFICIAL INTELLIGENCE IN GENOMICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 59. AUSTRALIA ARTIFICIAL INTELLIGENCE IN GENOMICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 60. CHINA ARTIFICIAL INTELLIGENCE IN GENOMICS MARKET SIZE, BY OFFERING, 2018-2030 (USD MILLION)
  • TABLE 61. CHINA ARTIFICIAL INTELLIGENCE IN GENOMICS MARKET SIZE, BY FUNCTION, 2018-2030 (USD MILLION)
  • TABLE 62. CHINA ARTIFICIAL INTELLIGENCE IN GENOMICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 63. CHINA ARTIFICIAL INTELLIGENCE IN GENOMICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 64. INDIA ARTIFICIAL INTELLIGENCE IN GENOMICS MARKET SIZE, BY OFFERING, 2018-2030 (USD MILLION)
  • TABLE 65. INDIA ARTIFICIAL INTELLIGENCE IN GENOMICS MARKET SIZE, BY FUNCTION, 2018-2030 (USD MILLION)
  • TABLE 66. INDIA ARTIFICIAL INTELLIGENCE IN GENOMICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 67. INDIA ARTIFICIAL INTELLIGENCE IN GENOMICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 68. INDONESIA ARTIFICIAL INTELLIGENCE IN GENOMICS MARKET SIZE, BY OFFERING, 2018-2030 (USD MILLION)
  • TABLE 69. INDONESIA ARTIFICIAL INTELLIGENCE IN GENOMICS MARKET SIZE, BY FUNCTION, 2018-2030 (USD MILLION)
  • TABLE 70. INDONESIA ARTIFICIAL INTELLIGENCE IN GENOMICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 71. INDONESIA ARTIFICIAL INTELLIGENCE IN GENOMICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 72. JAPAN ARTIFICIAL INTELLIGENCE IN GENOMICS MARKET SIZE, BY OFFERING, 2018-2030 (USD MILLION)
  • TABLE 73. JAPAN ARTIFICIAL INTELLIGENCE IN GENOMICS MARKET SIZE, BY FUNCTION, 2018-2030 (USD MILLION)
  • TABLE 74. JAPAN ARTIFICIAL INTELLIGENCE IN GENOMICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 75. JAPAN ARTIFICIAL INTELLIGENCE IN GENOMICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 76. MALAYSIA ARTIFICIAL INTELLIGENCE IN GENOMICS MARKET SIZE, BY OFFERING, 2018-2030 (USD MILLION)
  • TABLE 77. MALAYSIA ARTIFICIAL INTELLIGENCE IN GENOMICS MARKET SIZE, BY FUNCTION, 2018-2030 (USD MILLION)
  • TABLE 78. MALAYSIA ARTIFICIAL INTELLIGENCE IN GENOMICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 79. MALAYSIA ARTIFICIAL INTELLIGENCE IN GENOMICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 80. PHILIPPINES ARTIFICIAL INTELLIGENCE IN GENOMICS MARKET SIZE, BY OFFERING, 2018-2030 (USD MILLION)
  • TABLE 81. PHILIPPINES ARTIFICIAL INTELLIGENCE IN GENOMICS MARKET SIZE, BY FUNCTION, 2018-2030 (USD MILLION)
  • TABLE 82. PHILIPPINES ARTIFICIAL INTELLIGENCE IN GENOMICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 83. PHILIPPINES ARTIFICIAL INTELLIGENCE IN GENOMICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 84. SINGAPORE ARTIFICIAL INTELLIGENCE IN GENOMICS MARKET SIZE, BY OFFERING, 2018-2030 (USD MILLION)
  • TABLE 85. SINGAPORE ARTIFICIAL INTELLIGENCE IN GENOMICS MARKET SIZE, BY FUNCTION, 2018-2030 (USD MILLION)
  • TABLE 86. SINGAPORE ARTIFICIAL INTELLIGENCE IN GENOMICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 87. SINGAPORE ARTIFICIAL INTELLIGENCE IN GENOMICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 88. SOUTH KOREA ARTIFICIAL INTELLIGENCE IN GENOMICS MARKET SIZE, BY OFFERING, 2018-2030 (USD MILLION)
  • TABLE 89. SOUTH KOREA ARTIFICIAL INTELLIGENCE IN GENOMICS MARKET SIZE, BY FUNCTION, 2018-2030 (USD MILLION)
  • TABLE 90. SOUTH KOREA ARTIFICIAL INTELLIGENCE IN GENOMICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 91. SOUTH KOREA ARTIFICIAL INTELLIGENCE IN GENOMICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 92. TAIWAN ARTIFICIAL INTELLIGENCE IN GENOMICS MARKET SIZE, BY OFFERING, 2018-2030 (USD MILLION)
  • TABLE 93. TAIWAN ARTIFICIAL INTELLIGENCE IN GENOMICS MARKET SIZE, BY FUNCTION, 2018-2030 (USD MILLION)
  • TABLE 94. TAIWAN ARTIFICIAL INTELLIGENCE IN GENOMICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 95. TAIWAN ARTIFICIAL INTELLIGENCE IN GENOMICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 96. THAILAND ARTIFICIAL INTELLIGENCE IN GENOMICS MARKET SIZE, BY OFFERING, 2018-2030 (USD MILLION)
  • TABLE 97. THAILAND ARTIFICIAL INTELLIGENCE IN GENOMICS MARKET SIZE, BY FUNCTION, 2018-2030 (USD MILLION)
  • TABLE 98. THAILAND ARTIFICIAL INTELLIGENCE IN GENOMICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 99. THAILAND ARTIFICIAL INTELLIGENCE IN GENOMICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 100. VIETNAM ARTIFICIAL INTELLIGENCE IN GENOMICS MARKET SIZE, BY OFFERING, 2018-2030 (USD MILLION)
  • TABLE 101. VIETNAM ARTIFICIAL INTELLIGENCE IN GENOMICS MARKET SIZE, BY FUNCTION, 2018-2030 (USD MILLION)
  • TABLE 102. VIETNAM ARTIFICIAL INTELLIGENCE IN GENOMICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 103. VIETNAM ARTIFICIAL INTELLIGENCE IN GENOMICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 104. EUROPE, MIDDLE EAST & AFRICA ARTIFICIAL INTELLIGENCE IN GENOMICS MARKET SIZE, BY OFFERING, 2018-2030 (USD MILLION)
  • TABLE 105. EUROPE, MIDDLE EAST & AFRICA ARTIFICIAL INTELLIGENCE IN GENOMICS MARKET SIZE, BY FUNCTION, 2018-2030 (USD MILLION)
  • TABLE 106. EUROPE, MIDDLE EAST & AFRICA ARTIFICIAL INTELLIGENCE IN GENOMICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 107. EUROPE, MIDDLE EAST & AFRICA ARTIFICIAL INTELLIGENCE IN GENOMICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 108. EUROPE, MIDDLE EAST & AFRICA ARTIFICIAL INTELLIGENCE IN GENOMICS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 109. DENMARK ARTIFICIAL INTELLIGENCE IN GENOMICS MARKET SIZE, BY OFFERING, 2018-2030 (USD MILLION)
  • TABLE 110. DENMARK ARTIFICIAL INTELLIGENCE IN GENOMICS MARKET SIZE, BY FUNCTION, 2018-2030 (USD MILLION)
  • TABLE 111. DENMARK ARTIFICIAL INTELLIGENCE IN GENOMICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 112. DENMARK ARTIFICIAL INTELLIGENCE IN GENOMICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 113. EGYPT ARTIFICIAL INTELLIGENCE IN GENOMICS MARKET SIZE, BY OFFERING, 2018-2030 (USD MILLION)
  • TABLE 114. EGYPT ARTIFICIAL INTELLIGENCE IN GENOMICS MARKET SIZE, BY FUNCTION, 2018-2030 (USD MILLION)
  • TABLE 115. EGYPT ARTIFICIAL INTELLIGENCE IN GENOMICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 116. EGYPT ARTIFICIAL INTELLIGENCE IN GENOMICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 117. FINLAND ARTIFICIAL INTELLIGENCE IN GENOMICS MARKET SIZE, BY OFFERING, 2018-2030 (USD MILLION)
  • TABLE 118. FINLAND ARTIFICIAL INTELLIGENCE IN GENOMICS MARKET SIZE, BY FUNCTION, 2018-2030 (USD MILLION)
  • TABLE 119. FINLAND ARTIFICIAL INTELLIGENCE IN GENOMICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 120. FINLAND ARTIFICIAL INTELLIGENCE IN GENOMICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 121. FRANCE ARTIFICIAL INTELLIGENCE IN GENOMICS MARKET SIZE, BY OFFERING, 2018-2030 (USD MILLION)
  • TABLE 122. FRANCE ARTIFICIAL INTELLIGENCE IN GENOMICS MARKET SIZE, BY FUNCTION, 2018-2030 (USD MILLION)
  • TABLE 123. FRANCE ARTIFICIAL INTELLIGENCE IN GENOMICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 124. FRANCE ARTIFICIAL INTELLIGENCE IN GENOMICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 125. GERMANY ARTIFICIAL INTELLIGENCE IN GENOMICS MARKET SIZE, BY OFFERING, 2018-2030 (USD MILLION)
  • TABLE 126. GERMANY ARTIFICIAL INTELLIGENCE IN GENOMICS MARKET SIZE, BY FUNCTION, 2018-2030 (USD MILLION)
  • TABLE 127. GERMANY ARTIFICIAL INTELLIGENCE IN GENOMICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 128. GERMANY ARTIFICIAL INTELLIGENCE IN GENOMICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 129. ISRAEL ARTIFICIAL INTELLIGENCE IN GENOMICS MARKET SIZE, BY OFFERING, 2018-2030 (USD MILLION)
  • TABLE 130. ISRAEL ARTIFICIAL INTELLIGENCE IN GENOMICS MARKET SIZE, BY FUNCTION, 2018-2030 (USD MILLION)
  • TABLE 131. ISRAEL ARTIFICIAL INTELLIGENCE IN GENOMICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 132. ISRAEL ARTIFICIAL INTELLIGENCE IN GENOMICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 133. ITALY ARTIFICIAL INTELLIGENCE IN GENOMICS MARKET SIZE, BY OFFERING, 2018-2030 (USD MILLION)
  • TABLE 134. ITALY ARTIFICIAL INTELLIGENCE IN GENOMICS MARKET SIZE, BY FUNCTION, 2018-2030 (USD MILLION)
  • TABLE 135. ITALY ARTIFICIAL INTELLIGENCE IN GENOMICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 136. ITALY ARTIFICIAL INTELLIGENCE IN GENOMICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 137. NETHERLANDS ARTIFICIAL INTELLIGENCE IN GENOMICS MARKET SIZE, BY OFFERING, 2018-2030 (USD MILLION)
  • TABLE 138. NETHERLANDS ARTIFICIAL INTELLIGENCE IN GENOMICS MARKET SIZE, BY FUNCTION, 2018-2030 (USD MILLION)
  • TABLE 139. NETHERLANDS ARTIFICIAL INTELLIGENCE IN GENOMICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 140. NETHERLANDS ARTIFICIAL INTELLIGENCE IN GENOMICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 141. NIGERIA ARTIFICIAL INTELLIGENCE IN GENOMICS MARKET SIZE, BY OFFERING, 2018-2030 (USD MILLION)
  • TABLE 142. NIGERIA ARTIFICIAL INTELLIGENCE IN GENOMICS MARKET SIZE, BY FUNCTION, 2018-2030 (USD MILLION)
  • TABLE 143. NIGERIA ARTIFICIAL INTELLIGENCE IN GENOMICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 144. NIGERIA ARTIFICIAL INTELLIGENCE IN GENOMICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 145. NORWAY ARTIFICIAL INTELLIGENCE IN GENOMICS MARKET SIZE, BY OFFERING, 2018-2030 (USD MILLION)
  • TABLE 146. NORWAY ARTIFICIAL INTELLIGENCE IN GENOMICS MARKET SIZE, BY FUNCTION, 2018-2030 (USD MILLION)
  • TABLE 147. NORWAY ARTIFICIAL INTELLIGENCE IN GENOMICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 148. NORWAY ARTIFICIAL INTELLIGENCE IN GENOMICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 149. POLAND ARTIFICIAL INTELLIGENCE IN GENOMICS MARKET SIZE, BY OFFERING, 2018-2030 (USD MILLION)
  • TABLE 150. POLAND ARTIFICIAL INTELLIGENCE IN GENOMICS MARKET SIZE, BY FUNCTION, 2018-2030 (USD MILLION)
  • TABLE 151. POLAND ARTIFICIAL INTELLIGENCE IN GENOMICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 152. POLAND ARTIFICIAL INTELLIGENCE IN GENOMICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 153. QATAR ARTIFICIAL INTELLIGENCE IN GENOMICS MARKET SIZE, BY OFFERING, 2018-2030 (USD MILLION)
  • TABLE 154. QATAR ARTIFICIAL INTELLIGENCE IN GENOMICS MARKET SIZE, BY FUNCTION, 2018-2030 (USD MILLION)
  • TABLE 155. QATAR ARTIFICIAL INTELLIGENCE IN GENOMICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 156. QATAR ARTIFICIAL INTELLIGENCE IN GENOMICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 157. RUSSIA ARTIFICIAL INTELLIGENCE IN GENOMICS MARKET SIZE, BY OFFERING, 2018-2030 (USD MILLION)
  • TABLE 158. RUSSIA ARTIFICIAL INTELLIGENCE IN GENOMICS MARKET SIZE, BY FUNCTION, 2018-2030 (USD MILLION)
  • TABLE 159. RUSSIA ARTIFICIAL INTELLIGENCE IN GENOMICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 160. RUSSIA ARTIFICIAL INTELLIGENCE IN GENOMICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 161. SAUDI ARABIA ARTIFICIAL INTELLIGENCE IN GENOMICS MARKET SIZE, BY OFFERING, 2018-2030 (USD MILLION)
  • TABLE 162. SAUDI ARABIA ARTIFICIAL INTELLIGENCE IN GENOMICS MARKET SIZE, BY FUNCTION, 2018-2030 (USD MILLION)
  • TABLE 163. SAUDI ARABIA ARTIFICIAL INTELLIGENCE IN GENOMICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 164. SAUDI ARABIA ARTIFICIAL INTELLIGENCE IN GENOMICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 165. SOUTH AFRICA ARTIFICIAL INTELLIGENCE IN GENOMICS MARKET SIZE, BY OFFERING, 2018-2030 (USD MILLION)
  • TABLE 166. SOUTH AFRICA ARTIFICIAL INTELLIGENCE IN GENOMICS MARKET SIZE, BY FUNCTION, 2018-2030 (USD MILLION)
  • TABLE 167. SOUTH AFRICA ARTIFICIAL INTELLIGENCE IN GENOMICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 168. SOUTH AFRICA ARTIFICIAL INTELLIGENCE IN GENOMICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 169. SPAIN ARTIFICIAL INTELLIGENCE IN GENOMICS MARKET SIZE, BY OFFERING, 2018-2030 (USD MILLION)
  • TABLE 170. SPAIN ARTIFICIAL INTELLIGENCE IN GENOMICS MARKET SIZE, BY FUNCTION, 2018-2030 (USD MILLION)
  • TABLE 171. SPAIN ARTIFICIAL INTELLIGENCE IN GENOMICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 172. SPAIN ARTIFICIAL INTELLIGENCE IN GENOMICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 173. SWEDEN ARTIFICIAL INTELLIGENCE IN GENOMICS MARKET SIZE, BY OFFERING, 2018-2030 (USD MILLION)
  • TABLE 174. SWEDEN ARTIFICIAL INTELLIGENCE IN GENOMICS MARKET SIZE, BY FUNCTION, 2018-2030 (USD MILLION)
  • TABLE 175. SWEDEN ARTIFICIAL INTELLIGENCE IN GENOMICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 176. SWEDEN ARTIFICIAL INTELLIGENCE IN GENOMICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 177. SWITZERLAND ARTIFICIAL INTELLIGENCE IN GENOMICS MARKET SIZE, BY OFFERING, 2018-2030 (USD MILLION)
  • TABLE 178. SWITZERLAND ARTIFICIAL INTELLIGENCE IN GENOMICS MARKET SIZE, BY FUNCTION, 2018-2030 (USD MILLION)
  • TABLE 179. SWITZERLAND ARTIFICIAL INTELLIGENCE IN GENOMICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 180. SWITZERLAND ARTIFICIAL INTELLIGENCE IN GENOMICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 181. TURKEY ARTIFICIAL INTELLIGENCE IN GENOMICS MARKET SIZE, BY OFFERING, 2018-2030 (USD MILLION)
  • TABLE 182. TURKEY ARTIFICIAL INTELLIGENCE IN GENOMICS MARKET SIZE, BY FUNCTION, 2018-2030 (USD MILLION)
  • TABLE 183. TURKEY ARTIFICIAL INTELLIGENCE IN GENOMICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 184. TURKEY ARTIFICIAL INTELLIGENCE IN GENOMICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 185. UNITED ARAB EMIRATES ARTIFICIAL INTELLIGENCE IN GENOMICS MARKET SIZE, BY OFFERING, 2018-2030 (USD MILLION)
  • TABLE 186. UNITED ARAB EMIRATES ARTIFICIAL INTELLIGENCE IN GENOMICS MARKET SIZE, BY FUNCTION, 2018-2030 (USD MILLION)
  • TABLE 187. UNITED ARAB EMIRATES ARTIFICIAL INTELLIGENCE IN GENOMICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 188. UNITED ARAB EMIRATES ARTIFICIAL INTELLIGENCE IN GENOMICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 189. UNITED KINGDOM ARTIFICIAL INTELLIGENCE IN GENOMICS MARKET SIZE, BY OFFERING, 2018-2030 (USD MILLION)
  • TABLE 190. UNITED KINGDOM ARTIFICIAL INTELLIGENCE IN GENOMICS MARKET SIZE, BY FUNCTION, 2018-2030 (USD MILLION)
  • TABLE 191. UNITED KINGDOM ARTIFICIAL INTELLIGENCE IN GENOMICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 192. UNITED KINGDOM ARTIFICIAL INTELLIGENCE IN GENOMICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 193. ARTIFICIAL INTELLIGENCE IN GENOMICS MARKET SHARE, BY KEY PLAYER, 2023
  • TABLE 194. ARTIFICIAL INTELLIGENCE IN GENOMICS MARKET, FPNV POSITIONING MATRIX, 2023